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Abstract
Introduction: Tuberous sclerosis comple� (TSC) is a neurocutaneous syndrome produced by a number of genetic 
mutations. The disease is characterized by the development of benign tumors affecting different body systems. 
The most common oral manifestations of TSC are fibromas, gingival hyperplasia and enamel hypoplasia. 
Clinical Case: A 35-year-old woman diagnosed with TSC presented with a reactive fibroma of considerable size 
and rapid growth in the region of the right lower third molar. 
Discussion: In the present case the association of TSC with dental malpositioning gave rise to a rapidly evolving 
reactive fibroma of considerable diameter. Few similar cases can be found in the literature. Patients with TSC 
present mutations of the TSC1 and TSC2 genes� which intervene in cell cycle regulation and are important for 
avoiding neoplastic processes. No studies have been found associating TSC with an increased risk of oral cancer� 
though it has been shown that the over-e�pression of TSC2 could e�ert an antitumor effect. Careful oral and dental 
hygiene� together with regular visits to the dentist� are needed for the prevention and early detection of any type 
of oral lesion. The renal� pulmonary and cardiac alterations often seen in TSC must be taken into account for the 
correct management of these patients.
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Introduction
Tuberous sclerosis comple� (TSC) is a neurocutaneous 
syndrome characterized by the development of benign 
tumors such as neurofibromas and angiofibromas locat-
ed anywhere in the body (skin� central nervous system� 
heart� kidneys� etc.). 
Patients with TSC present mutations of the TSC1 and 
TSC2 genes� which intervene in cell cycle regulation. 
This is a dominant autosomal hereditary disease� though 
60-70% of all cases are the result of spontaneous muta-
tions (1�2). The prevalence of TSC ranges from 1:6�000 
to 1:10�000 individuals� and the diagnosis is usually es-
tablished between 4-10 years of age or in puberty (3).
TSC manifests with variable signs and symptoms to-
gether with angiofibromas distributed in a characteristic 
“butterfly” pattern on the face and forehead. The most 
important neurological problems are mental retarda-
tion, seizures, autism and learning difficulties. The di-
agnostic criteria of TSC have been divided into major 
and minor features (Table 1). The presence of two major 
characteristics or of one major criterion and two minor 
criteria confirms the diagnosis. A molecular diagnosis 
is advised in patients at risk� in order to diagnose the 
disease before the actual symptoms appear (1�3�4).
The cerebral manifestations and renal complications of 
TSC exert an important influence upon patient progno-
sis (4).
The most common oral manifestations of TSC are fibro-
mas� gingival hyperplasia and enamel hypoplasia (5). 
Other less frequent findings in the oral cavity are a high 
arched palate, bifid uvula, harelip and/or cleft palate, 
delayed dental eruption and the presence of diastemas 
(6).
Clinical Case
A 35-year-old woman was seen in the Service of Oral 
Surgery (Dental Clinic of the University of Barcelona� 
Spain) in March 2009 for the evaluation of continuous� 
intense pain for the past two days� located in the right 
hemimandibular region. The patient e�plained that she 
noticed the appearance of an asymptomatic mass in the 
right lower third molar region a few months ago� and 
that the lesion had gradually grown since then.
TSC had been diagnosed at age 23 years as a result of 
the presence of Koenen tumors on the face, fingers and 
toes� lumbar connective tissue nevus� parascapular hy-
pomelanocytic macula� and enamel hypoplasia of the 
left upper central incisor. Magnetic resonance imaging� 
funduscopy and abdominal ultrasound were also per-
formed� revealing the presence of renal alterations. In 
1999 the patient underwent kidney transplantation due 
to chronic renal failure secondary to angiomyolipomas� 
and two years later bilateral breast fibroadenomas were 
removed and a simple total hysterectomy was performed 
due to multiple uterine fibromatosis. On several occa-
sions she underwent surgery for the removal of Koenen 
tumors, angiofibromas and epidermoid cysts in the fa-
cial region. Posteriorly� in 2005� right and left radical 
nephrectomy was carried out. 
At the time of her visit to our Service� the patient was 
taking the following medication: 5 mg of glucocorti-
coids daily via the oral route (Dacortin® 5 mg; Merck� 
Madrid� Spain)� 250 mg of cyclosporine daily via the 
oral route (Sandimmun neural® 50 mg; Novartis� Bar-
celona� Spain)� and 20 mg of enalapril maleate daily via 
the oral route (Renitec® 5 mg; Merck� Madrid� Spain).
Oral and dental e�ploration revealed the presence of a 
papillomatous tumor of the same color as the oral mu-
cosa and measuring 2.5 cm in diameter� enveloping the 
right lower third molar� which in turn showed grade 3 
mobility (Fig. 1A). A lesion of similar characteristics 
but smaller size (1 cm) was identified in association to 
the root fragments of the left lower third molar (Fig. 
1B). The lesions were asymptomatic� but percussion of 
the right lower third molar caused pain.
A panoramic radiography and a computed tomography 
scan of the mandible and upper maxilla (Fig. 2A-B) 
showed well defined radiotransparencies with regular 
margins in the region of the lower third molars. The 
lower third molars were removed and the associated le-
sions were resected. The histopathological study of the 
tumor tissue confirmed the presence of reactive fibroma 
(Fig. 3A-B).
Major criteria 
- Facial angiofibromas
- Multiple ungual fibromas (Koenen tumors)
- Cortical tubercle
- Subependymal nodule
- Multiple astrocytomas
- Renal angiolipomas
- Hypomelanocytic maculae (3 or more) 
- Cardiorhabdomyomas 
Minor criteria 
- Cerebral tubercles 
- Non-calcified subependymal nodules 
- Hamartomatous rectal polyps 
- Gingival fibromas 
- Non-renal hamartomas 
- Multiple renal cysts 
- Retinal hamartomas 
- Enamel hypoplasia 
Table 1. Diagnostic criteria of tuberous sclerosis comple� 
(TSC).
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Fig. 1. Clinical e�amination. A. Lesion associated to the right 
lower third molar. B. Lesion related to the root remains of the 
left lower third molar.
Fig. 2. Radiological study. A. Panoramic radiography (March 2009). 
B. Sagittal and coronal views of the computed tomography scan 
(April 2009).
Fig. 3. Histological study (hematoxylin-eosin stain). A. Chronic inflammation with epithelial hyperplasia is observed (x100). B. Collagen-
containing fibrous tissue fragments are seen, with few cells, enveloping remains of odontogenic epithelium (x200).
A
A
B
B
B
A B
Med Oral Patol Oral Cir Bucal. 2011 Jul 1;16 (4):e478-81.                                                                                                                                                   Tuberous sclerosis with oral manifestations
e481
Discussion
Tuberous sclerosis comple� (TSC) is often associated 
with mental retardation (in 70% of cases) and epilepsy 
(90%). Koenen tumors and angiofibromas in turn are 
observed in 15-20% and 70% of all cases� respectively. 
Renal angiomyolipomas and cysts affect one-half of 
patients with TSC and are the cause of chronic renal 
failure that may prove fatal. Cardiac rhabdomyomas are 
normally observed before age 25 years in 30-50% of all 
cases� and are also a cause of early death (4�7). Our pa-
tient presented Koenen tumors� renal oncocytomas and 
angiomyolipomas, angiofibromas and enamel hypopla-
sia� but no mental retardation or epilepsy.
The most common oral manifestations of TSC are fi-
brous hyperplasias and enamel hypoplasia (7). The 
former are more often found in the gingival zones of the 
anterior sector� though involvement of the lips� tongue 
and palate is not unusual. According to some authors� 
these hyperplasias may be secondary to the medica-
tion usually taken by these patients (8). The incidence 
of oral fibromas in TSC varies according to the differ-
ent literature sources between 50-69%� with an average 
diameter of 5 mm (9-12). The aggressivity of the lesions 
depends on the severity of the local factors. Our patient 
presented a rapidly evolving reactive fibroma measur-
ing 2.5 cm in diameter� associated to a malpositioned 
lower third molar. The literature offers no evidence of 
similar oral fibromas.
It should be noted that these patients present mutations 
of the TSC1 and TSC2 genes. These genes intervene 
in cell cycle regulation and are important for avoiding 
neoplastic processes (13). No studies have been found 
associating TSC with an increased risk of oral cancer� 
though according to Kawaguchi et al. (14)� TSC2 over-
e�pression could e�ert an antitumor effect in oral can-
cer, since it is an oncosuppressor gene. Fleury et al. (15) 
published a case of undifferentiated pleomorphic sar-
coma located in the mandible of a patient with TSC.
Enamel hypoplasia is present in the permanent denti-
tion of almost 100% of these patients� and is associated 
with an increased risk of caries. This anomaly typically 
affects the vestibular surfaces of several teeth. No spe-
cific studies have been published on the oral hard tissue 
manifestations of TSC. According to Barron et al. (16)� 
mesenchymal tumors such as my�oma� desmoplastic 
fibroma and odontogenic fibroma can be found in the 
ma�illas of patients diagnosed with this disease. A cor-
rect differential diagnosis of these lesions must be es-
tablished in order to apply adequate treatment (15�16).
Patients with TSC must adopt measures for careful oral 
and dental hygiene� with regular visits to the dentist� in 
order to eliminate potential irritative factors and ensure 
the early diagnosis of any possible lesions. The oral 
healthcare professional in turn must always request a 
detailed medical report on the condition of the patient. 
Due to the frequent renal� cardiac and pulmonary al-
terations� general anesthesia� intravenous sedation and 
pre- and postoperative medication must be administered 
with caution.
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